Regulating Laboratory Tests: What Framework Would Best Support Safety and Validity?

Area of Science:

• Medical Diagnostics
• Regulatory Science
• Public Health Policy

Background:

• Growing concerns regarding inaccurate and misleading laboratory-developed tests (LDTs).
• Need for a regulatory framework balancing test validation with laboratory innovation.
• Previous legislative attempts like the VALID Act did not pass.

Purpose of the Study:

• To highlight the necessity of regulatory reform for laboratory-developed tests.
• To discuss the potential impact of the VALID Act on test safety and validity.
• To address the FDA's current path towards regulatory reform in the absence of the VALID Act.

Main Methods:

• Policy analysis of the VALID Act's provisions.
• Review of public discourse on LDT regulation.
• Examination of the FDA's regulatory authority and proposed actions.

Main Results:

• The VALID Act proposed expanding FDA oversight for in vitro clinical tests (IVCTs).
• Failure to pass the VALID Act necessitates alternative regulatory strategies by the FDA.
• The FDA is initiating its own regulatory reform process for LDTs.

Conclusions:

• Patient safety necessitates robust oversight of laboratory-developed tests.
• A balanced regulatory approach is crucial for both test accuracy and innovation.
• The FDA's independent regulatory efforts are critical in the absence of comprehensive legislation.